1. Production and Characterization of Chitooligosaccharides: Evaluation of Acute Toxicity, Healing, and Anti-Inflammatory Actions.
- Author
-
de Andrade RCLC, de Araújo NK, Torres-Rêgo M, Furtado AA, Daniele-Silva A, de Souza Paiva W, de Medeiros Dantas JM, da Silva NS, da Silva-Júnior AA, Ururahy MAG, de Assis CF, De Santis Ferreira L, Rocha HAO, and de Freitas Fernandes-Pedrosa M
- Subjects
- 3T3 Cells, Animals, Anti-Inflammatory Agents chemistry, Bacillus enzymology, Biocompatible Materials chemistry, Cell Movement drug effects, Cell Survival drug effects, Chitosan chemistry, Cytokines metabolism, Disease Models, Animal, Ear Diseases chemically induced, Edema chemically induced, Female, Fibroblasts drug effects, Fibroblasts metabolism, Glycoside Hydrolases chemistry, Hydrolysis, Inflammation drug therapy, Inflammation metabolism, Leukocytes drug effects, Leukocytes metabolism, Male, Mice, Mice, Inbred BALB C, Oligosaccharides chemistry, Anti-Inflammatory Agents administration & dosage, Biocompatible Materials administration & dosage, Chitosan administration & dosage, Ear Diseases drug therapy, Edema drug therapy, Oligosaccharides administration & dosage, Wound Healing drug effects
- Abstract
The search for promising biomolecules such as chitooligosaccharides (COS) has increased due to the need for healing products that act efficiently, avoiding complications resulting from exacerbated inflammation. Therefore, this study aimed to produce COS in two stages of hydrolysis using chitosanases derived from Bacillus toyonensis. Additionally, this study aimed to structurally characterize the COS via mass spectrometry, to analyze their biocompatibility in acute toxicity models in vivo, to evaluate their healing action in a cell migration model in vitro, to analyze the anti-inflammatory activity in in vivo models of xylol-induced ear edema and zymosan-induced air pouch, and to assess the wound repair action in vivo. The structural characterization process pointed out the presence of hexamers. The in vitro and in vivo biocompatibility of COS was reaffirmed. The COS stimulated the fibroblast migration. In the in vivo inflammatory assays, COS showed an antiedematogenic response and significant reductions in leukocyte migration, cytokine release, and protein exudate. The COS healing effect in vivo was confirmed by the significant wound reduction after seven days of the experiment. These results indicated that the presence of hexamers influences the COS biological properties, which have potential uses in the pharmaceutical field due to their healing and anti-inflammatory action.
- Published
- 2021
- Full Text
- View/download PDF